Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

6 Nov 2014 17:07

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) has been informed that today Virginia Kamsky, a Non-Executive Director of the Company, acquired an interest in 5,000 ordinary 25p shares in the Company (“Shares”) by means of the purchase of 1,250 American Depositary Receipts (“ADRs”) (one ADR being equivalent to four Shares) on the New York Stock Exchange at a price of 606.07 pence per share (being the equivalent of US$38.74 per ADR using an exchange rate of 1.5980). Ms Kamsky now holds an interest in a total of 10,000 Shares.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FCA’s Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

6 November 2014

Copyright Business Wire 2014

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.